| ||
Representative(s): Allison Cressman Christine Furjanic Jarad Babcock Tim Wheeler Dan Morgan Stephanie Hackbart
| At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma. Company Website: Virtual Booth:
| Virtual Drop In:March 6th, 7:45 am Click here to join the zoom meeting Meeting ID: 961 0683 2938 Dial by your location
|


